Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AT 501

Next Previous
Search
Drug Profile

AT 501

Alternative Names: AT-501 - Medigen Vaccine Biologics; AT501; H7N9 influenza vaccine - Medigen Vaccine Biologics; Influenza A virus vaccine H7N9 - Medigen Vaccine Biologics

Latest Information Update: 08 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator National Health Research Institutes
  • Developer Medigen Vaccine Biologics
  • Class Influenza A virus H7N9 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Influenza A virus H7N9 subtype

Most Recent Events

  • 08 Oct 2021 AT 501 is still in phase-I/II clinical development in Influenza-A virus H7N9 subtype (Prevention) in Taiwan (Medigen Vaccine Biologics website, October 2021)
  • 03 Aug 2017 AT 501 is still in phase-I/II clinical development in Influenza-A virus H7N9 subtype (Prevention, In adults) in Taiwan (Medigen Vaccinology website, August 2017)
  • 01 Feb 2016 Medigen completes phase-I/II clinical trials in Influenza-A virus H7N9 subtype (Prevention, In adults) in Taiwan (Parenteral) (NCT02436928)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top